Literature DB >> 9831807

CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells.

C B López1, A M Kalergis, M I Becker, J A Garbarino, A E De Ioannes.   

Abstract

BACKGROUND: The exposure of human skin to leaves and branches of litre (Lithraea caustica), a Chilean endemic tree, induces a severe contact dermatitis characterized by swelling and pruritus in susceptible individuals. The allergenic priniciple of litre is 3-pentadecyl (10-enyl) catechol (litreol), which is structurally similar to the allergens isolated from poison oak and poison ivy. All of them belong to a family of compounds named urushiols. As a proelectrophilic allergen, litreol must be intracellularly activated before modifying proteins of individuals exposed to it. As a result, self-peptides derived from litreol-modified intracellular proteins would be presented in the context of class I MHC molecules. We hypothesized that CD8+ T lymphocytes would play a major role during the effector phase of the immune response induced by those modified peptides. In order to test this hypothesis, we investigated the cellular immune response to litreol in Balb/cJ mice. The role of the different lymphocyte subpopulations in this response was assessed by immunodepleting mice of CD4+ or CD8+ T lymphocytes using specific monoclonal antibodies (mAbs). We report the observation that the contact dermatitis induced by litreol has two components: a primary response which does not require TCRalpha beta+ T cells, and a secondary response mediated mainly by CD8+ T cells and regulated by CD4+ T cells. Our results show that CD8+ lymphocytes play a central role as effectors of the secondary response to litreol. Furthermore, our data suggest that two functionally different CD4+ T subpopulations serve as regulators of the CD8+ T cell function: a CD4+ T helper population sensitive to a low dose of the depleting mAb, and CD4+ T suppressor population which is eliminated only with a high dose of depleting mAb.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831807     DOI: 10.1159/000024010

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Polymerized urushiol of the commercially available rhus product in Korea.

Authors:  Seung Hyun Cheong; You Won Choi; Byung Sun Min; Hae Young Choi
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

2.  Clinical Features of Systemic Contact Dermatitis Due to the Ingestion of Lacquer in the Province of Chungcheongnam-do.

Authors:  Jung Eun Kim; Sung Yul Lee; Jong Suk Lee; Young Lip Park; Kyu Uang Whang
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

Review 3.  Biologic functions of the IFN-gamma receptors.

Authors:  G Tau; P Rothman
Journal:  Allergy       Date:  1999-12       Impact factor: 13.146

4.  Lithraea caustic (Litre) Extract Promotes an Antitumor Response Against B16 Melanoma.

Authors:  Claudia Robles-Planells; Sofia A Michelson; Javier Mena; Daniela Escrig; Juan L Rojas; Giselle Sanchez-Guerrero; Ronny Hernández; Carlos Barrera-Avalos; Leonel E Rojo; Daniela Sauma; Alexis M Kalergis; Mónica Imarai; Ricardo Fernández; Carolina A Robles; Elías Leiva-Salcedo; Rocio Santander; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

5.  Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1.

Authors:  Miyako Nagamachi; Daiji Sakata; Kenji Kabashima; Tomoyuki Furuyashiki; Takahiko Murata; Eri Segi-Nishida; Kitipong Soontrapa; Toshiyuki Matsuoka; Yoshiki Miyachi; Shuh Narumiya
Journal:  J Exp Med       Date:  2007-10-29       Impact factor: 14.307

6.  MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.

Authors:  Inken M Beck; René Rückert; Katja Brandt; Markus S Mueller; Thorsten Sadowski; Rena Brauer; Peter Schirmacher; Rolf Mentlein; Radislav Sedlacek
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.